Voyager Therapeutics (VYGR) Assets Growth (3y) (2017 - 2026)

Voyager Therapeutics (VYGR) Assets Growth (3y) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Voyager Therapeutics 183.84 Mn 42.36 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.28%
Dec 31, 2025 16.55%
Sep 30, 2025 16.47%
Jun 30, 2025 19.53%
Mar 31, 2025 16.37%
Dec 31, 2024 26.57%
Sep 30, 2024 32.11%
Jun 30, 2024 27.85%
Mar 31, 2024 25.47%
Dec 31, 2023 10.33%
Sep 30, 2023 2.99%
Jun 30, 2023 1.99%
Mar 31, 2023 1.39%
Dec 31, 2022 -23.41%
Sep 30, 2022 -21.43%
Jun 30, 2022 -21.41%
Mar 31, 2022 -18.32%
Dec 31, 2021 3.07%
Sep 30, 2021 -2.12%
Jun 30, 2021 -0.93%